Table 3. Presence of chronic underlying conditions in hospitalised COVID-19 cases, I-MOVE-COVID-19 hospital surveillance network, Europe, February 2020–December 2021 (n = 25,971).
Conditions | COVID-19 cases (n = 25,971) | ICU/HDU (n = 3,196) | Deaths (n = 4,306) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Yes | No | Missing | Yes | No | Missing | Yes | No | Missing | ||||||||||
n | %a | n | %a | n | %b | n | %a | n | %a | n | %b | n | %a | n | %a | n | %b | |
Hypertension | 7,393 | 43.6 | 9,575 | 56.4 | 9,003 | 34.7 | 1,198 | 46.9 | 1,359 | 53.1 | 639 | 20.0 | 1,765 | 59.7 | 1,189 | 40.3 | 1,352 | 31.4 |
Heart disease | 6,396 | 32.6 | 13,224 | 67.4 | 6,351 | 24.5 | 730 | 26.8 | 1,995 | 73.2 | 471 | 14.7 | 1,839 | 52.3 | 1,678 | 47.7 | 789 | 18.3 |
Obesity | 4,660 | 27.1 | 12,549 | 72.9 | 8,762 | 33.7 | 939 | 36.9 | 1,609 | 63.1 | 648 | 20.3 | 751 | 23.9 | 2,386 | 76.1 | 1,169 | 27.1 |
Diabetes | 4,996 | 26.1 | 14,122 | 73.9 | 6,853 | 26.4 | 800 | 29.5 | 1,914 | 70.5 | 482 | 15.1 | 1,200 | 35.1 | 2,221 | 64.9 | 885 | 20.6 |
Cancer | 2,882 | 16.5 | 14,536 | 83.5 | 8,553 | 32.9 | 323 | 13.3 | 2,105 | 86.7 | 768 | 24.0 | 783 | 24.6 | 2,401 | 75.4 | 1,122 | 26.1 |
Asthma | 1,828 | 10.0 | 16,409 | 90.0 | 7,734 | 29.8 | 219 | 8.3 | 2,414 | 91.7 | 563 | 17.6 | 364 | 11.0 | 2,958 | 89.0 | 984 | 22.9 |
Lung diseasec | 2,897 | 15.7 | 15,538 | 84.3 | 7,536 | 29.0 | 400 | 15.0 | 2,262 | 85.0 | 534 | 16.7 | 798 | 24.5 | 2,465 | 75.5 | 1,043 | 24.2 |
Renal disease | 2,924 | 15.4 | 16,051 | 84.6 | 6,996 | 26.9 | 326 | 12.0 | 2,398 | 88.0 | 472 | 14.8 | 961 | 28.5 | 2,416 | 71.5 | 929 | 21.6 |
Neuromuscular disorder | 1,469 | 10.2 | 12,901 | 89.8 | 11,601 | 44.7 | 121 | 5.4 | 2,121 | 94.6 | 954 | 29.8 | 424 | 16.2 | 2,195 | 83.8 | 1,687 | 39.2 |
Stroke | 729 | 6.4 | 10,729 | 93.6 | 14,513 | 55.9 | 73 | 4.6 | 1,503 | 95.4 | 1,620 | 50.7 | 216 | 13.1 | 1,429 | 86.9 | 2,661 | 61.8 |
Rheumatic illness | 1,068 | 6.3 | 15,847 | 93.7 | 9,056 | 34.9 | 124 | 5.5 | 2,132 | 94.5 | 940 | 29.4 | 282 | 9.2 | 2,797 | 90.8 | 1,227 | 28.5 |
Dementia | 912 | 5.8 | 14,813 | 94.2 | 10,246 | 39.5 | 22 | 1.1 | 1,936 | 98.9 | 1,238 | 38.7 | 349 | 12.2 | 2,502 | 87.8 | 1,455 | 33.8 |
Liver disease | 972 | 5.2 | 17,825 | 94.8 | 7,174 | 27.6 | 150 | 5.5 | 2,557 | 94.5 | 489 | 15.3 | 211 | 6.3 | 3,148 | 93.7 | 947 | 22.0 |
Anaemia | 578 | 5.0 | 10,959 | 95.0 | 14,434 | 55.6 | 86 | 5.4 | 1,501 | 94.6 | 1,609 | 50.3 | 131 | 7.9 | 1,520 | 92.1 | 2,655 | 61.7 |
Immunodeficiency | 542 | 3.2 | 16,654 | 96.8 | 8,775 | 33.8 | 91 | 3.8 | 2,295 | 96.2 | 810 | 25.3 | 150 | 4.8 | 2,994 | 95.2 | 1,162 | 27.0 |
Tuberculosis | 81 | 1.1 | 7,616 | 98.9 | 18,274 | 70.4 | 15 | 1.1 | 1,340 | 98.9 | 1,841 | 57.6 | 13 | 1.1 | 1,137 | 98.9 | 3,156 | 73.3 |
Aspleniad | 93 | 1.0 | 9,435 | 99.0 | 16,443 | 63.3 | < 10 | < 1.0 | > 1,000 | > 99.0 | 1,945 | 60.9 | 27 | 1.4 | 1,909 | 98.6 | 2,370 | 55.0 |
HDU: high dependency unit; ICU: intensive care unit; I-MOVE: Influenza-Monitoring Vaccine Effectiveness in Europe.
a Percentage of hospital admissions with non-missing data.
b Percentage is the proportion with missing chronic condition data.
c Differences between sites meant that asthma was occasionally included in lung disease.
d These values are not presented because of small numbers and to prevent disclosure.